AMENDED AND RESTATED EQUITY COMMITMENT LETTER August 14, 2020Navidea Biopharmaceuticals, Inc. • August 14th, 2020 • In vitro & in vivo diagnostic substances • New York
This letter agreement sets forth the commitment of Mastiff Group LLC as lead investor (the “Sponsor”), subject to the terms and conditions contained herein, to purchase, directly or indirectly, certain equity interests of Navidea Biopharmaceuticals, Inc., corporation incorporated under the Laws of Delaware (“NAVB”). This Amended and Restated Equity Commitment Letter supersedes and replaces those letters dated August 9, 2020 and August 13, 2020, which are hereby terminated by mutual agreement.
